Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Stage II-III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06926543
What this trial is testing

Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy

Who this might be right for
Invasive Breast CancerStage III Breast CancerStage IIB Breast Cancer
Dr. Tabassum Wadasadawala 858
Large-scale testing (Phase 3)Study completedNCT00311636
What this trial is testing

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast Cancer
Gruppo Italiano Mammella (GIM) 280
Testing effectiveness (Phase 2)Ended earlyNCT01147016
What this trial is testing

Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 8
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07631052
What this trial is testing

Capecitabine in ER+/HER2-negative Breast Cancer

Who this might be right for
ER-positive, HER2-negative Breast CancerBreast Cancer Stage IBreast Cancer Stage II+1 more
University Health Network, Toronto 15
Testing effectiveness (Phase 2)Study completedNCT01328249
What this trial is testing

Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer

Who this might be right for
HER2-normal
Eisai Inc. 81
Large-scale testing (Phase 3)Study completedNCT05555706
What this trial is testing

Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Shanghai Jiaolian Drug Research and Development Co., Ltd 62
Not applicableLooking for participantsNCT06247449
What this trial is testing

MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer

Who this might be right for
Breast Cancer
Sunnybrook Health Sciences Centre 100
Large-scale testing (Phase 3)Study completedNCT01433562
What this trial is testing

Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients

Who this might be right for
Breast Cancer
Dexa Medica Group 40
Large-scale testing (Phase 3)Active Not RecruitingNCT03414970
What this trial is testing

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

Who this might be right for
Ductal Breast CarcinomaInvasive Breast CarcinomaLobular Breast Carcinoma+6 more
Alliance for Clinical Trials in Oncology 898
Large-scale testing (Phase 3)Study completedNCT00005079
What this trial is testing

Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03106077
What this trial is testing

Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+18 more
M.D. Anderson Cancer Center 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT03879577
What this trial is testing

Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer

Who this might be right for
Breast CancerBreast Cancer FemaleHER2-positive Breast Cancer+2 more
University of Chicago 53
Not applicableStudy completedNCT05025748
What this trial is testing

Ask Questions (ASQ):Implementation of a Communication Intervention

Who this might be right for
Stage II Breast CancerStage III Breast CancerStage IV Breast Cancer+20 more
Barbara Ann Karmanos Cancer Institute 81
Not applicableStudy completedNCT04999826
What this trial is testing

Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+19 more
Mayo Clinic 105
Large-scale testing (Phase 3)Study completedNCT00002784
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 344
Testing effectiveness (Phase 2)UnknownNCT03818685
What this trial is testing

Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease

Who this might be right for
Breast CancerTriple Negative Breast Neoplasms
Centre Leon Berard 95
Not applicableUnknownNCT01560663
What this trial is testing

Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer

Who this might be right for
Breast CancerBreast Cancer Stage II-III
Miguel Martín Jiménez 415
Not applicableActive Not RecruitingNCT07259304
What this trial is testing

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+97 more
University of Southern California 118
Not applicableStudy completedNCT05674578
What this trial is testing

Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more
Ohio State University Comprehensive Cancer Center 21
Next Page